Claret Capital Partners Raises €575M for European Growth
Claret Capital Partners Closes €575M Fund IV London-based Claret Capital Partners has raised €575 million through Fund IV and an affiliated discretionary mandate. This surpassed its original €500 million fundraising The post Claret Capital Partners Raises €575M for European Growth appeared first on Ventureburn .
London-based investment firm Claret Capital Partners has successfully raised €575 million for its fourth growth debt fund, surpassing its €500 million target. Fund IV, comprising €440 million in investor commitments and €135 million through an affiliated discretionary mandate, brings the firm's total capital raised since inception to €1.3 billion.
Claret has invested over €1.5 billion since 2013 and supports more than 210 companies across technology, life sciences, and impact sectors. The company plans to deploy Fund IV across Europe's technology and life sciences ecosystems, providing growth debt to help companies reduce equity dilution and support various stages of business expansion, such as organic growth, acquisitions, research, development, and capital expenditures.
Claret's flexible approach to growth capital allows companies to access funding without immediately issuing additional equity. The firm has already deployed 32% of Fund IV across 27 companies, including Billie, a B2B buy-now-pay-later platform, Cinclus Pharma, and clinical-stage biotech Inventiva. Claret's latest raise reflects confidence in Europe's technology and life sciences sectors and positions the firm to finance more European technology and life sciences businesses, as it plans to expand its presence across Europe's major innovation hubs, including Paris and Berlin.
Written by urgent.news from Ventureburn's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
